Management of Pulmonary Hypertension Associated with Left Heart Disease

被引：4

作者：

Franco, Veronica ^{[1
]}

机构：

[1] Ohio State Univ, Div Cardiovasc Dis, Pulm Hypertens Program, Adv Heart Failure LVAD & Transplantat Program, DHLRI Suite 200,473 West 12th Ave, Columbus, OH 43210 USA

来源：

HEART FAILURE CLINICS | 2018年 / 14卷 / 04期

关键词：

Hypertension; Heart failure; Ejection fraction; Right ventricular; Pulmonary hypertension; Pulmonary arterial hypertension; GUANYLATE-CYCLASE STIMULATOR; PRESERVED EJECTION FRACTION; VENTRICULAR ASSIST DEVICE; DOUBLE-BLIND; INTERNATIONAL SOCIETY; CLINICAL-OUTCOMES; PRESSURE-GRADIENT; LISTING CRITERIA; FLUID CHALLENGE; FAILURE;

D O I：

10.1016/j.hfc.2018.06.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Pulmonary hypertension (PH) due to left heart disease, or WHO group 2 PH, is the most frequent cause of PH. It affects approximately 50% to 60% of patients with heart failure with preserved ejection fraction as well as 60% of those with heart failure with reduced ejection fraction and contributes significantly to disease progression and unfavorable outcomes. The diagnosis of PH is associated with poor prognosis and significant morbidity and mortality.

引用

页码：545 / +

页数：8

共 50 条

[21] Pulmonary hypertension in left heart disease
Opitz, C. F.
Glaeser, S.
Ewert, R.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 : S167 - S169
[22] Challenges in pulmonary hypertension associated with left heart disease
Zolty, Ronald
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2019, 17 (06) : 461 - 472
[23] Pulmonary hypertension associated with left heart disease: recommendations of the Cologne Consensus Conference 2016
Rosenkranz, S.
Lang, I. M.
Blindt, R.
Bonderman, D.
Bruch, L.
Diller, G. P.
Felgendreher, R.
Gerges, C.
Hohenforst-Schmidt, W.
Holt, S.
Jung, C.
Kindermann, I.
Kramer, T.
Kuebler, W. M.
Mitrovic, V.
Riedel, A.
Rieth, A.
Schmeisser, A.
Wachter, R.
Weil, J.
Opitz, C.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 : S48 - +
[24] Pulmonary hypertension associated with left-sided heart failure
Adler, Joana
Gerhardt, Felix
Wissmueller, Max
Adler, Christoph
Baldus, Stephan
Rosenkranz, Stephan
CURRENT OPINION IN CARDIOLOGY, 2020, 35 (06) : 610 - 619
[25] Pulmonary Hypertension Due to Left Heart Diseases
Vachiery, Jean-Luc
Adir, Yochai
Albert Barbera, Joan
Champion, Hunter
Coghlan, John Gerard
Cottin, Vincent
De Marco, Teresa
Galie, Nazzareno
Ghio, Stefano
Gibbs, J. Simon R.
Martinez, Fernando
Semigran, Marc
Simonneau, Gerald
Wells, Athol
Seeger, Werner
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (25) : D100 - D108
[26] Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications
Omote, Kazunori
Sorimachi, Hidemi
Obokata, Masaru
Reddy, Yogesh N., V
Verbrugge, Frederik H.
Omar, Massar
DuBrock, Hilary M.
Redfield, Margaret M.
Borlaug, Barry A.
EUROPEAN HEART JOURNAL, 2022, 43 (36) : 3417 - 3431
[27] The pathophysiology of pulmonary hypertension in left heart disease
Breitling, Siegfried
Ravindran, Krishnan
Goldenberg, Neil M.
Kuebler, Wolfgang M.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 309 (09) : L924 - L941
[28] Pulmonary Hypertension Due to Left Heart Disease
Gerges, Mario
Gerges, Christian
Naeije, Robert
Lang, Irene M.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (05) : 662 - 676
[29] Pulmonary Hypertension Due to Left Heart Disease
Guazzi, Marco
Borlaug, Barry A.
CIRCULATION, 2012, 126 (08) : 975 - 990
[30] Pulmonary hypertension in left heart disease: A review
Corte, Tamera J.
McDonagh, Theresa A.
Wort, Stephen J.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 156 (03) : 253 - 258

← 1 2 3 4 5 →